Related Experiment Video
Updated: Jul 23, 2026
09:44
High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
Published on: March 3, 2015
Strategic pooling of compounds for high-throughput screening.
1Department of Biomolecular Structure, Glaxo Wellcome Research and Development, Medicines Research Centre, Stevenage, Hertfordshire, U.K.
Journal of Chemical Information and Computer Sciences
|October 26, 1999
Summary
Pooling compounds for high-throughput screening (HTS) accelerates drug discovery. Careful compound selection is crucial to minimize reactivity risks within screening pools.
Area of Science:
- Drug discovery and development
- Medicinal chemistry
- Biotechnology
Background:
- Rapid drug discovery is essential for bringing new medicines to market.
- High-throughput screening (HTS) is a key process involving testing numerous compounds.
- Pooling compounds in HTS can increase efficiency and reduce costs.
Purpose of the Study:
- To investigate the impact of compound pooling on high-throughput screening.
- To identify risks associated with pooling compounds for biological testing.
- To provide guidance on selecting compounds for pooled screening.
Main Methods:
- Theoretical analysis of compound interactions in pools.
- Experimental validation of compound reactivity within pooled sets.
- Data analysis to assess the effect of pooling strategies.
Main Results:
- Compound pooling can introduce reactivity risks.
- Careful selection of compounds is necessary to mitigate these risks.
- Both theoretical and experimental data support the need for strategic pooling.
Conclusions:
- Strategic compound selection is vital for successful pooled HTS.
- Minimizing inter-compound reactivity enhances the reliability of drug screening.
- Optimized pooling strategies improve the efficiency of drug discovery pipelines.
